InMed Pharmaceuticals Inc. News, InMed Pharmaceuticals Inc. Quote, INM Quote

InMed Pharmaceuticals Inc. (NQ:INM) Delayed: 0.25 -0.05 (16.67%)

Prev. Close

$0.30

Open

$0.26

52 Wk High

$0.00

52 Wk Low

$0.00

Day High

$0.27

Day Low

$0.25

P/E

N/A

EPS

$0.00

Volume

623,391

Friends, Peers and Foes (?): ANP, QBTS ZYME (more...)

Apr 18, 2024 01:31 PM Form 8-K InMed Pharmaceuticals For: Apr 18
Apr 18, 2024 08:03 AM InMed Pharmaceuticals Inc. (INM)Appoints David G. Morgan to its Board
Apr 18, 2024 08:02 AM InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board
Apr 16, 2024 02:40 PM Form 8-K InMed Pharmaceuticals For: Apr 16
Apr 16, 2024 08:01 AM InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
Apr 5, 2024 11:27 AM Form 8-K InMed Pharmaceuticals For: Apr 04
Apr 4, 2024 08:02 AM InMed Pharmaceuticals (INM) Reports INM-901 Demonstrated Favorable Pharmacological and Behavioral Effects
Apr 4, 2024 08:02 AM InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies
Mar 20, 2024 01:44 PM Form 8-K InMed Pharmaceuticals For: Mar 19
Mar 20, 2024 08:33 AM InMed Pharmaceuticals (INM) Granted Nasdaq Extension to Regain Compliance

Entities mentioned with INM